Monitor this situation.
Unsubscribe anytime.
[SITUATION] · [ACTIVE] · [HEALTH]
9 clusters · 12 sources · 66 days · First seen · Last updated
South Korea telemedicine and pharmaceutical delivery debate
Overview
South Korea is experiencing significant tension regarding telemedicine regulations and the expansion of pharmaceutical delivery services. The National Assembly passed an amendment to the Pharmaceutical Affairs Act, known as the ‘Doctor Now Prevention Act’, which prohibits telemedicine platforms from acting as pharmaceutical wholesalers to prevent conflicts of interest and illegal rebates. While the pharmaceutical industry welcomed this, the venture and startup sectors argue the law stifles innovation by banning entire business models.
The government has proposed expanding medicine delivery to all telemedicine patients, moving beyond current restrictions for vulnerable groups. The Korean Pharmaceutical Association (KPA) has launched large-scale protests against this, with over 10,000 members rallying in Gwanghwamun. The KPA argues that expansion without sufficient safety measures could lead to drug misuse, medicine degradation, and compromised medical data. To intensify opposition, the KPA has maintained an emergency response committee to fight against drug delivery expansion and the expansion of over-the-counter medicine categories.
Medical professionals have also intensified calls to halt expansions. The Korean Medical Association of Private Practitioners (KMAP) warned that prioritizing convenience over physical examinations could lead to misdiagnosis of acute conditions, noting over 10,000 cases of potential drug abuse involving narcotics during pilot programs. Specialist groups, including otolaryngologists, ophthalmologists, and dermatologists, have joined the opposition, arguing that specialized equipment and physical examinations of texture or depth cannot be replaced by video or photos.
As the government moves toward final negotiations scheduled for December 24, key contentions remain regarding the proposed expansion of first-visit telemedicine and the controversial provision allowing up to 30-day prescriptions for initial visits if deemed necessary by a professional.
Entities
Ministry of Health and Welfare · Korean Pharmaceutical Association · Ministry of SMEs and Startups · Kwon Young-hee · National Assembly of South Korea
Claims
What the coverage asserts, and how many sources carry each claim.
- [● 5 SOURCES] The Korean Pharmaceutical Association (KPA) held a rally with over 10,000 participants in Gwanghwamun.
- [● 4 SOURCES] The KPA opposes the expansion due to concerns over drug misuse and medicine degradation.
- [● 3 SOURCES] The government plans to expand medicine delivery to all telemedicine patients.
- [● 3 SOURCES] The current telemedicine law limits delivery to specific groups like the disabled and residents of remote areas.
- [● 2 SOURCES] Patient and consumer groups support the expansion to ensure medical access.
- [● 2 SOURCES] The Remote Healthcare Industry Association has called for dialogue to design safe delivery systems.
- [○ 1 SOURCE] The KPA plans to move protests to the National Assembly.
Timeline
-
[HEALTH] 2 sourcesSouth Korean medical community debates telemedicine regulations
South Korean medical groups are negotiating with the government over telemedicine rules, citing concerns over misdiagnosis and prescription safety for initial visits.
-
[HEALTH] 4 sourcesSouth Korean medical associations oppose telemedicine expansion
South Korean medical associations are protesting government plans to expand telemedicine, citing risks of misdiagnosis and the necessity of in-person examinations for specialized care.
-
[HEALTH] 2 sourcesSouth Korea proposes expanding first-visit telemedicine scope
South Korea's Ministry of Health and Welfare proposed expanding first-visit telemedicine, sparking backlash from medical associations over concerns regarding misdiagnosis and drug abuse risks.
-
[BUSINESS] 2 sourcesKorean Pharmaceutical Association maintains emergency committee
The Korean Pharmaceutical Association will maintain its current emergency committee after a vote to form a new body failed. The group pledged to fight against telemedicine drug delivery and OTC medicine reforms
-
[HEALTH] 3 sourcesKorean medical practitioners warn against unsafe telemedicine expansion
South Korean medical practitioners warn that expanding telemedicine without strict safety protocols risks misdiagnosis and drug abuse, while also opposing the entry of traditional medicine into aesthetics.
-
[HEALTH] 5 sourcesKorean Pharmaceutical Association protests medicine delivery expansion
Over 10,000 pharmacists in South Korea protested against government plans to expand medicine delivery for telemedicine patients, citing concerns over drug safety, misuse, and platform commercialization.
-
[HEALTH] 2 sourcesSouth Korean medical groups urge halt to telemedicine and drug delivery expansion
South Korean medical and pharmaceutical groups are demanding a halt to telemedicine expansion and drug delivery services, citing risks of medication misuse and patient safety concerns.
-
[HEALTH] 2 sourcesKorean Pharmaceutical Association opposes expanded medicine delivery
The Korean Pharmaceutical Association is boycotting government talks on expanding medicine delivery for telemedicine patients, calling the move “desk administration” that ignores safety and local needs.
-
[HEALTH] 5 sourcesSouth Korea passes law restricting telemedicine platform wholesaling
South Korea passed a law restricting telemedicine platforms from acting as wholesalers, while the government moves to expand medicine delivery to all telemedicine patients amid industry protests.
Sources
biz.heraldcorp.com · blockchainseoul.kr · bokuennews.com · bosa.co.kr · english.hani.co.kr · healthfocus.co.kr · hin.company · mbn.co.kr · newstomato.com · platum.kr · startuprecipe.co.kr · zdnet.co.kr
This summary has been updated 9 times: see revision history